Example: Heart Attack
Clinical Trials Sponsored by British Columbia Clinical Genomics Network
Total 2 results
-
NCT01118130RecruitingConditions: Multiple Sclerosis
-
NCT00414115RecruitingConditions: Adverse Drug Reaction (ADR)
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Show vendors
Medical Conditions
- COVID-19
- Monkeypox
- Arsenic Poisoning Chronic
- Cerebral Cavernous Hemangioma
- Covid19
- Frail
- Inflammaging
- Inspiratory Muscle Weakness
- Metastatic Epidural Spinal Cord Compression
- Metastatic Malignant Female Reproductive System Neoplasm
- Mitral Disease
- Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8
- Recurrent Verrucous Carcinoma of the Larynx
- Root Canal Treatment
- Wegener's
- View Full List
Sponsors and Collaborators
- CIBER (Infectious diseases)
- Cancer Research UK
- Chongqing Three Gorges Central Hospital
- Department of ophthalmology, General Hospital Linz
- Finnish MS Society
- Genesis Center for Fertility & Human Pre-Implantation Genetics
- Italian Multiple Sclerosis Foundation
- Mejeribrugets ForskningsFond
- National Taipei University of Technology
- Richard Lane
- Shanghai 6F+ High-risk Infants Early Intervention Center
- Société Française de lutte contre les cancers et leucémies de l'enfant et de l'adolescent (SFCE)
- Todos Medical, Ltd.
- View Full List